img

Global Brain Cancer Targeted Drug Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Brain Cancer Targeted Drug Market Research Report 2024

A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist. 
According to Mr Accuracy reports new survey, global Brain Cancer Targeted Drug market is projected to reach US$ 2326.4 million in 2029, increasing from US$ 1248 million in 2022, with the CAGR of 9.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Brain Cancer Targeted Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Brain Cancer Targeted Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck & Co.
Roche
Novartis
Segment by Type
Belzutifan (Welireg)
Bevacizumab (Avastin)
Everolimus (Afinitor)

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Brain Cancer Targeted Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Targeted Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Belzutifan (Welireg)
1.2.3 Bevacizumab (Avastin)
1.2.4 Everolimus (Afinitor)
1.3 Market by Application
1.3.1 Global Brain Cancer Targeted Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Targeted Drug Market Perspective (2018-2029)
2.2 Brain Cancer Targeted Drug Growth Trends by Region
2.2.1 Global Brain Cancer Targeted Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Brain Cancer Targeted Drug Historic Market Size by Region (2018-2024)
2.2.3 Brain Cancer Targeted Drug Forecasted Market Size by Region (2024-2029)
2.3 Brain Cancer Targeted Drug Market Dynamics
2.3.1 Brain Cancer Targeted Drug Industry Trends
2.3.2 Brain Cancer Targeted Drug Market Drivers
2.3.3 Brain Cancer Targeted Drug Market Challenges
2.3.4 Brain Cancer Targeted Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Targeted Drug Players by Revenue
3.1.1 Global Top Brain Cancer Targeted Drug Players by Revenue (2018-2024)
3.1.2 Global Brain Cancer Targeted Drug Revenue Market Share by Players (2018-2024)
3.2 Global Brain Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Cancer Targeted Drug Revenue
3.4 Global Brain Cancer Targeted Drug Market Concentration Ratio
3.4.1 Global Brain Cancer Targeted Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Targeted Drug Revenue in 2022
3.5 Brain Cancer Targeted Drug Key Players Head office and Area Served
3.6 Key Players Brain Cancer Targeted Drug Product Solution and Service
3.7 Date of Enter into Brain Cancer Targeted Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Targeted Drug Breakdown Data by Type
4.1 Global Brain Cancer Targeted Drug Historic Market Size by Type (2018-2024)
4.2 Global Brain Cancer Targeted Drug Forecasted Market Size by Type (2024-2029)
5 Brain Cancer Targeted Drug Breakdown Data by Application
5.1 Global Brain Cancer Targeted Drug Historic Market Size by Application (2018-2024)
5.2 Global Brain Cancer Targeted Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Brain Cancer Targeted Drug Market Size (2018-2029)
6.2 North America Brain Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Brain Cancer Targeted Drug Market Size by Country (2018-2024)
6.4 North America Brain Cancer Targeted Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Targeted Drug Market Size (2018-2029)
7.2 Europe Brain Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Brain Cancer Targeted Drug Market Size by Country (2018-2024)
7.4 Europe Brain Cancer Targeted Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Targeted Drug Market Size (2018-2029)
8.2 Asia-Pacific Brain Cancer Targeted Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Targeted Drug Market Size (2018-2029)
9.2 Latin America Brain Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Brain Cancer Targeted Drug Market Size by Country (2018-2024)
9.4 Latin America Brain Cancer Targeted Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Targeted Drug Market Size (2018-2029)
10.2 Middle East & Africa Brain Cancer Targeted Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Detail
11.1.2 Merck & Co. Business Overview
11.1.3 Merck & Co. Brain Cancer Targeted Drug Introduction
11.1.4 Merck & Co. Revenue in Brain Cancer Targeted Drug Business (2018-2024)
11.1.5 Merck & Co. Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Brain Cancer Targeted Drug Introduction
11.2.4 Roche Revenue in Brain Cancer Targeted Drug Business (2018-2024)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Brain Cancer Targeted Drug Introduction
11.3.4 Novartis Revenue in Brain Cancer Targeted Drug Business (2018-2024)
11.3.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Brain Cancer Targeted Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Belzutifan (Welireg)
Table 3. Key Players of Bevacizumab (Avastin)
Table 4. Key Players of Everolimus (Afinitor)
Table 5. Global Brain Cancer Targeted Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Brain Cancer Targeted Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Brain Cancer Targeted Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Brain Cancer Targeted Drug Market Share by Region (2018-2024)
Table 9. Global Brain Cancer Targeted Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Brain Cancer Targeted Drug Market Share by Region (2024-2029)
Table 11. Brain Cancer Targeted Drug Market Trends
Table 12. Brain Cancer Targeted Drug Market Drivers
Table 13. Brain Cancer Targeted Drug Market Challenges
Table 14. Brain Cancer Targeted Drug Market Restraints
Table 15. Global Brain Cancer Targeted Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Brain Cancer Targeted Drug Market Share by Players (2018-2024)
Table 17. Global Top Brain Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Targeted Drug as of 2022)
Table 18. Ranking of Global Top Brain Cancer Targeted Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Brain Cancer Targeted Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Brain Cancer Targeted Drug Product Solution and Service
Table 22. Date of Enter into Brain Cancer Targeted Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Brain Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Brain Cancer Targeted Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Brain Cancer Targeted Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Brain Cancer Targeted Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Brain Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Brain Cancer Targeted Drug Revenue Market Share by Application (2018-2024)
Table 30. Global Brain Cancer Targeted Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Brain Cancer Targeted Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Brain Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Brain Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Brain Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Brain Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Brain Cancer Targeted Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Brain Cancer Targeted Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Brain Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Brain Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Brain Cancer Targeted Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Brain Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Merck & Co. Company Detail
Table 48. Merck & Co. Business Overview
Table 49. Merck & Co. Brain Cancer Targeted Drug Product
Table 50. Merck & Co. Revenue in Brain Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 51. Merck & Co. Recent Development
Table 52. Roche Company Detail
Table 53. Roche Business Overview
Table 54. Roche Brain Cancer Targeted Drug Product
Table 55. Roche Revenue in Brain Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Brain Cancer Targeted Drug Product
Table 60. Novartis Revenue in Brain Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Research Programs/Design for This Report
Table 63. Key Data Information from Secondary Sources
Table 64. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Cancer Targeted Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Brain Cancer Targeted Drug Market Share by Type: 2022 VS 2029
Figure 3. Belzutifan (Welireg) Features
Figure 4. Bevacizumab (Avastin) Features
Figure 5. Everolimus (Afinitor) Features
Figure 6. Global Brain Cancer Targeted Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Brain Cancer Targeted Drug Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Brain Cancer Targeted Drug Report Years Considered
Figure 12. Global Brain Cancer Targeted Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Brain Cancer Targeted Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Brain Cancer Targeted Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Brain Cancer Targeted Drug Market Share by Players in 2022
Figure 16. Global Top Brain Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Targeted Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Brain Cancer Targeted Drug Revenue in 2022
Figure 18. North America Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Brain Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 20. United States Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Brain Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 24. Germany Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Brain Cancer Targeted Drug Market Share by Region (2018-2029)
Figure 32. China Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Brain Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 40. Mexico Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Brain Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 44. Turkey Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Brain Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Merck & Co. Revenue Growth Rate in Brain Cancer Targeted Drug Business (2018-2024)
Figure 47. Roche Revenue Growth Rate in Brain Cancer Targeted Drug Business (2018-2024)
Figure 48. Novartis Revenue Growth Rate in Brain Cancer Targeted Drug Business (2018-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed